Collaboration and integration to progress clinical research europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.
Supported by Sanofi
In the midst of the pandemic in September 2020, European Commission president Ursula von der Leyen announced the creation of a new organisation to help deal with such disastrous health issues: the Health Emergency Preparedness and Response Authority (HERA). Exactly what it will do, how and with what money, remain open questions as we enter 2021; member states are still discussing the plans. But it is clear to all that such an authority would be a major, and important, departure in EU efforts to promote its citizens’ health.
To help elucidate some of the open questions, Science|Business on 14 January 2021 organised an online conference about HERA. In an effort to widen that debate on a matter of vital public interest, this impartial document reports on the questions raised – with a call for policy makers to consider their answers carefully before acting.
(1)
NIJMEGEN, Netherlands, Jan. 28, 2021 /PRNewswire/
To take AI development in pathology to the next level, a European consortium combining leading European research centres, hospitals as well as major pharmaceutical industries, is going to develop a repository for the sharing of pathology data. The 6-year, €70 million project called BIGPICTURE, will herald a new era in pathology.
Background: Sectra contributes to accelerate AI innovation for diagnostics in digital pathology
Sectra engages in the new EU Innovative Medicines Initiative project BIGPICTURE to construct a large-scale database of pathology images. Sectra s contributions will help accelerate the development of improved diagnostic methods based on artificial intelligence, supporting an effective interplay between healthcare and academic research. The Sectra efforts include a close collaboration with the BIGPICTURE partners Center for Medical Image Science and Visualization (CMIV) at Linköping University and Regio
E-Mail
A new consortium of the EU Innovative Medicines Initiative (IMI) aims to establish the biggest database of pathology images to accelerate the development of artificial intelligence in medicine.
To take AI development in pathology to the next level, a European consortium combining leading European research centres, hospitals as well as major pharmaceutical industries, is going to develop a repository for the sharing of pathology data. The 6-year, €70 million project called BIGPICTURE, will herald a new era in pathology.
Pathology is the cornerstone of the workup of many diseases such as cancer, autoimmune diseases, of the follow up after transplantation and is also critical for the evaluation of the safety of drugs. It s based on the examination of tissue samples (slides) under the microscope. However, despite its pivotal role, it still relies heavily on the qualitative interpretation by a qualified pathologist.